ADVA
11.5.2022 09:02:09 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that Westfalen Weser Netz has deployed its ALM fiber monitoring technology for precise, real-time insight into its regional metro network. The solution gives the municipal utility provider complete infrastructure assurance. Now it can instantly detect and rapidly repair fiber breaks with minimal disruption. The ADVA ALM enables Westfalen Weser Netz to dramatically shorten repair cycles and enhance network performance. It also means far fewer truck rolls and significant savings on fuel cost. The technology integrated seamlessly into Westfalen Weser Netz’s cableScout® management software provided by ADVA’s partner JO Software Engineering GmbH.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510005843/en/
“The ADVA ALM is helping us ensure excellent network availability while also reducing maintenance effort and expense. It gives our repair teams the power to remotely measure attenuation and quickly locate any degradation in our fiber plant. They can then take action straightaway to resolve problems,” said Stefan Kenneweg, consultant at Westfalen Weser Netz. “Combining the ADVA ALM assurance solution with our cableScout® management software is like turning on the lights right across our network. Now there are no more blind spots. That means no more wasted hours on false alarms and no nasty surprises for our customers.”
The ADVA ALM is now delivering passive, in-service monitoring of Westfalen Weser Netz’s fiber links. The simple, plug-and-play device offers several key advantages for utility network assurance. Its fanless operation and compact, low-energy design reduce opex and environmental impact. It’s also a highly robust solution ready to be installed in almost any location. Built on standardized, open management interfaces, the ADVA ALM is fully interoperable with Westfalen Weser Netz’s existing cableScout® software. This provides a geographic information system (GIS) to quickly and easily locate failures.
“Our ALM fiber monitoring platform is already bringing major benefits to Westfalen Weser Netz and its customers, helping the company reduce truck rolls and maximize resource efficiency. There really is no technology that has this much impact with such little cost and effort,” commented Hartmut Müller-Leitloff, SVP of sales, EMEA at ADVA. “When it comes to providing homes and businesses with safe, efficient and sustainable electricity, gas and water, the reliability of the data transport network is crucial. Now that Westfalen Weser Netz has total visibility and control of its fiber infrastructure, it can avoid outages and introduce new services with confidence.”
“Our cableScout® platform combined with the ADVA ALM solution for in-service monitoring provides Westfalen Weser Netz with continual access to a detailed layout of its network. Its team now has comprehensive understanding of the complete fiber architecture, enabling efficient end-to-end planning, management and troubleshooting,” said Ralph Kosztovits, managing partner at JO Software Engineering GmbH. “ADVA is a company that shares our commitment to sustainable growth and creating new opportunities through innovation. Our close alliance offers major benefits for network operators like Westfalen Weser Netz who are committed to empowering customers to achieve more and enhancing end user experience.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
Published by:
ADVA Optical Networking SE, Munich, Germany
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005843/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom